Show Summary Details
Page of

Pharmacological management 

Pharmacological management
Pharmacological management

Roy S. Gardner

, Theresa A. McDonagh

, and Niki L. Walker

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 22 February 2020

The medical treatment of heart failure has been revolutionized by large randomized controlled clinical trials studying the effects of antagonists of the renin–angiotensin–aldosterone and sympathetic nervous systems. These drugs now form the cornerstones in the management of the condition, with recognized and proven reductions in morbidity and mortality. This chapter gives and overview of the pharmacological options available for patients with heart failure.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.